Jardiance 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FKQBN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,088
Award facts
- Contract value 100% obligated
- $54,087.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Jardiance 10 mg tablets (90-count packaging) with a ceiling value of $54,087.85. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by September 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceuticals, specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen provides critical medical commodities to customers including the Defense Health Agency and U.S. Coast Guard, with the DLA Troop Support planning to establish multiple Pharmaceutical Prime Vendor Global Program Generation V contracts across different regions to optimize medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FKQBN?
SPE2DB25FKQBN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FKQBN worth?
The government has obligated $54,088 on SPE2DB25FKQBN.
Is contract SPE2DB25FKQBN an order under another contract?
Yes. SPE2DB25FKQBN is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKQBN competed?
The extent of competition for SPE2DB25FKQBN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award